Multiple studies have described acquired resistance to sunitinib in tumor cells [25] as a transient form of insensitivity to VEGFR inhibition [26] that could likely be driven by dynamic epigenetic regulation [27,28,29] rather than a stable genetic form of resistance. This evidence concerns the gene KDR and neoplasm.